Clinical Program Leader

Novartis Pharma AG; Basel; On-site; CHF 170,000 - 280,000; Full time

Benefits offered by this job

Hybrid working options

Parental leave 14 weeks

Insurance plans

Retirement plans

Job summary

Novartis AG in Basel seeks a senior CPL to provide strategic medical leadership for oncology projects from preclinical stages through early development. You will craft clinical development strategies, align with IDPA, and lead cross-functional teams to drive programs toward Transition Decision Point (TDP).

The role requires leadership in integrating preclinical data, PK/PD concepts, and regulatory requirements, with strong medical writing and collaboration across functions.

Qualifications

• MD or DO degree.
• Board-certification in oncology is preferred; PhD-level science is a plus.
• Minimum of 2 years of industry experience in pharma/biotech.
• Experience interpreting preclinical oncology data; PK/PD knowledge is important.

Responsibilities

• Provide strategic medical leadership for oncology projects from preclinical to early development.
• Create clinical development strategies within PE/DC to TDP, coordinating with multidisciplinary teams.
• Lead Early Program Teams (BPTs) to enable clinical development and trials.
• Develop protocols and instruments for clinical studies and collaborate with scientists.

Skills

Medical leadership

Clinical development

Regulatory liaison

Biostatistics

GCP knowledge

Education

MD or DO

Oncology board certification

PhD preferred

Job description

Location: Basel

Experience will determine which level 6 (Senior CPL or CPL) after interview process.

CPL: Provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, beginning with PE / DC (Portfolio Entry / Drug Candidate) of preclinical development and continuing through TDP (Transition Decision Point).

About the Role

Major Accountabilities

• Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE / DC
• Creates clinical development strategies for new oncology agents within the PE/ DC to TDP timeframe. The development strategy combines the CPL’s medical knowledge with the expertise of colleagues in a wide range of other disciplines (e.g., Clinical Pharmacology, Biostatistics) to optimize the clinical development strategy. Delivers solutions within functions, across functions, and on global projects, developing independent approach to TCO strategy.
• Although registration studies are not within the responsibility of TCO, the CPL must provide an early clinical development strategy that foresees and supports subsequent registration trials. Development of the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads (DALs), Development (DEV), Strategy & Growth (S&G), and Commercial teams
• Lead Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP. May lead multiple global project teams
• Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator’s Brochure and First-in-Human protocol
• Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develop the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports)
• Applies own medical knowledge to guide the safe, ethical and efficient conduct of the trials under own responsibility. Knowledgeable in Good Clinical Practice guidelines and Novartis Standard Operating Procedures and strives to maintain compliance with them
• Liaises with outside experts, investigators, and regulatory authorities in oncology, and represents own projects to those groups and authorities
• Writes and reviews abstracts/manuscripts etc. for presentation/publications at internal/external meetings
• Participates in task forces to support continuous improvement and other management objectives. Operational responsibility for quality and compliance
• May provide informal mentorship to less experienced CPLs

Qualifications:

Education:

MD or DO degree

Board-certification in an oncology specialty and PhD-level science is preferred

Languages:

Fluent English – Oral and written

Experience/Professional requirement:

• A minimum of 2 years of industry experience within pharmaceutical or biotechnology organizations is required, including experience contributing to and driving early clinical oncology programs.
• Experience in the interpretation of preclinical oncology data, including molecular biology, pharmacology, pharmacokinetics, and toxicology, is also required. Prior experience in early-phase oncology at an academic medical center is highly desirable.
• Recognized as an expert in your field by external medical experts and regulatory authorities. External candidates have a substantial record of publication and international recognition
• Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
• Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
• Proven ability to analyze and interpret efficacy and safety data relating to oncology
• Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
• Excellent medical/scientific writing skills
• Successful track record of strategic thinking: created major innovations with successful outcomes for patients
• Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
• Excellent personal ethical integrity and a commitment to improving the outcomes for patients with malignancies
• Excellent written and oral English communication/presentation skills
• Strong office IT skills

Rewards

At Novartis,we’recommitted to reimagining medicine together - and rewarding the people who make it happen.

The rewards of being part of our team go far beyond base pay and incentives.We also offer a variety of competitive benefits inkindto help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeingresourcesand global recognition programs. In addition, we provide flexible and hybrid working options, where possible, anda minimum of14 weekspaid parental leave.

Expected Annual Base Salary Range for role:

The salary offered isdeterminedbased on gender-neutralobjectives, such as relevant skills,competenciesand experiencein accordance withthe Novartis pay setting policy and upon joining Novartis will be reviewed periodically.

In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. Further details will be provided during the application process.

Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse,equitableand inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics.

Note: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. A full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the applicationprocess.

Commitment to Diversity and Inclusion / EEO paragraph:

Novartis is committed to building an outstanding, inclusive work environment and diverseteams’representativeof the patients and communities we serve.

Why Novartis:Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating,supportingand inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture